New Drugs Need Agile Biomanufacturing

Last month, NNE’s Jeffery Odum offered his views on intelligent biomanufacturing and the factory of the future in the session, “Addressing Unique Challenges of Patient-Centric Supply Chain Needs,” March 21, at the 2018 PDA Annual Meeting in Orlando.

He took the time to answer a few questions about how innovative products, such as advanced therapy medicinal products (ATMPs), will affect pharmaceutical manufacturing for the PDA Letter.